Neuronal downregulation of impairs synaptic function and elicits Alzheimer disease hallmarks
Audrey Coulon,Florian Rabiller,Mari Takalo,Avishek Roy,Henna Martiskainen,Dolores Siedlecki-Wullich,Tiago Mendes,Celia Lemeu,Lukas-Iohan Carvalho,Anaël Ehrardt,Ana Raquel Melo de Farias,Marc Hulsman,Chloé Najdek,Nina Lannette-Weimann,Alejandra Freire-Regatillo,Philippe Amouyel,Camille Charbonnier,Orio Dols-Icardo,Heli Jeskanen,Roosa-Maria Willman,Teemu Kuulasmaa,Mitja Kurki,John Hardy,Richard Wagner,Sami Heikkinen,Henne Holstege,Petra Mäkinen,Gaël Nicolas,Simon Mead,Michael Wagner,Alfredo Ramirez,Tuomas Rauramaa,Aarno Palotie,Rebecca Sims,Hilkka Soininen,John van Swieten,Julie Williams,Céline Bellenguez,Benjamin Grenier-Boley,Carla Gelle,Erwan Lambert,Anne-Marie Ayral,Florie Demiautte,Marcos R. Costa,Séverine Deforges,Devrim Kilinc,Christophe Mulle,Julien Chapuis,Mikko Hiltunen,Julie Dumont,Jean-Charles Lambert
DOI: https://doi.org/10.1101/2024.04.29.591575
2024-05-01
Abstract:We developed a high content screening to investigate how Alzheimer disease (AD) genetic risk factors may impair synaptic mechanisms in rat primary neuronal cultures. Out of the gene targets identified, we found that shRNA-mediated downregulation of in mouse dentate gyrus neurons consistently impaired dendritic morphology and synaptic function. In human neuronal cultures (hNCs), downregulation also impaired synaptic function and was associated with increased levels of Aβ and Tau phosphorylation, potentially the AKT/GSK3β axis. Very rare loss-of-function (LoF) variants were associated with a 10-fold increased AD risk. LoF carriers exhibit low mRNA/protein PLCγ2 levels, consistent with nonsense-mediated mRNA decay mechanisms. Restoring PLCγ2 levels in shPLCG2-hNCs fully reversed the disease-related phenotypes. Our findings indicate that the downregulation of PLCγ2 increases the risk of AD by impairing synaptic function and increasing the levels of Aβ and Tau phosphorylation in neurons.
Neuroscience